Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies
Nonmyeloablative haploidentical bone marrow transplantation with post-transplantation cyclophosphamide in pediatric patients with high-risk hematologic malignancies is a safe and effective treatment Outcomes for pediatric and young adult patients are comparable to published adult outcomes